Filing Details

Accession Number:
0000899243-21-021981
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-04 14:29:38
Reporting Period:
2021-06-02
Accepted Time:
2021-06-04 14:29:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1787400 Nkarta Inc. NKTX Pharmaceutical Preparations (2834) 474515206
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1853197 Ralph Brandenberger C/O Nkarta, Inc.
6000 Shoreline Court, Suite 102
South San Francisco CA 94080
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-02 340 $0.41 340 No 4 M Direct
Common Stock Acquisiton 2021-06-02 405 $4.77 745 No 4 M Direct
Common Stock Acquisiton 2021-06-02 1,358 $3.89 2,103 No 4 M Direct
Common Stock Acquisiton 2021-06-02 2,037 $3.89 4,140 No 4 M Direct
Common Stock Disposition 2021-06-02 4,140 $24.50 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-06-02 340 $0.00 340 $0.41
Common Stock Stock Option (right to buy) Disposition 2021-06-02 405 $0.00 405 $4.77
Common Stock Stock Option (right to buy) Disposition 2021-06-02 1,358 $0.00 1,358 $3.89
Common Stock Stock Option (right to buy) Disposition 2021-06-02 2,037 $0.00 2,037 $3.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,387 2028-07-18 No 4 M Direct
10,000 2029-05-10 No 4 M Direct
33,500 2029-09-05 No 4 M Direct
50,250 2029-09-05 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
  2. The option is vested and exercisable as to 6,498 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022.
  3. The option is vested and exercisable as to 5,721 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022.
  4. The option is vested and exercisable as to 5,583 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.
  5. The option is vested and exercisable as to 18,561 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.